Back

Omecamtiv Mecarbil in Patients with Severe Heart Failure: An Analysis from Global Approach to Lowering Adverse Cardiac Outcomes through Improving Contractility in Heart Failure (GALACTIC-HF)

29 June 2021 (08:00 - 08:00)
Organised by:
Congress Presentation Part of: Clinical Trial Updates Pharmacotherapy HFA Premium Access Heart Failure 2021

About the speaker

Photo
Professor G Michael Felker

Duke University Medical Center, Durham (United States of America)

13 More presentations in this session

Presentation thumbnail
Association of Baseline Cardiac Biomarkers on Clinical Outcomes and Vericiguat Treatment Effect in Heart Failure with Reduced Ejection Fraction: Insights from the VICTORIA Trial
Associate Professor C. DeFilippi (Baltimore, US)
Slides Video
Presentation thumbnail
Efficacy and Safety of Antithrombotic Strategies in Patients With Atrial Fibrillation and Recent ACS or PCI With and Without A History of Heart Failure: Insights From the AUGUSTUS Trial
Doctor M. Fudim (Durham, US)
Slides Video
Presentation thumbnail
Nurse Intervention for Less Chronic Heart Failure Study
Professor S. Stewart (Fremantle, AU)
Slides Video
Presentation thumbnail
Efficacy of omecamtiv mecarbil in heart failure with reduced ejection fraction according to N-terminal pro-B-type natriuretic peptide level: Insights from the GALACTIC-HF trial.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
Telemedical Interventional Management in Heart Failure
Professor F. Koehler (Berlin, DE)
Slides Video

Access the full session

Session thumbnail
Clinical Trial Updates

The Event

Event poster

Heart Failure 2021

29 June 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Omecamtiv mecarbil
20 May 2023
thumbnail
Congress Presentation
The evolution of the obstructive HCM therapeutic landscape: emerging evidence about cardiac myosin inhibitors
31 August 2025
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Results of the DOLMEN registry: modulation of cardiac contractility for the management of patients with advanced heart failure
20 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources